Literature DB >> 18767892

NICE Guide to the Methods of Technology Appraisal: pharmaceutical industry perspective.

Julia Earnshaw, Gavin Lewis.   

Abstract

Mesh：

Year:  2008        PMID： 18767892     DOI： 10.2165/00019053-200826090-00002

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  6 in total

1.  Estimating 'costs' for cost-effectiveness analysis.

Authors:  Alec Miners
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 2.  The NICE cost-effectiveness threshold: what it is and what that means.

Authors:  Christopher McCabe; Karl Claxton; Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 3.  Use of indirect and mixed treatment comparisons for technology assessment.

Authors:  Alex Sutton; A E Ades; Nicola Cooper; Keith Abrams
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Exploring uncertainty in cost-effectiveness analysis.

Authors:  Karl Claxton
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 5.  Valuing health States for use in cost-effectiveness analysis.

Authors:  John Brazier
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  Subgroups and heterogeneity in cost-effectiveness analysis.

Authors:  Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
  6 in total
  44 in total

1.  Guidelines for conducting and reporting economic evaluation of fall prevention strategies.

Authors:  J C Davis; M C Robertson; T Comans; P A Scuffham
Journal:  Osteoporos Int       Date:  2010-11-23       Impact factor: 4.507

2.  NICE's 2008 Methods Guide: sensible consolidation or opportunities missed?

Authors:  Mark Sculpher
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Converting Parkinson-Specific Scores into Health State Utilities to Assess Cost-Utility Analysis.

Authors:  Gang Chen; Miguel A Garcia-Gordillo; Daniel Collado-Mateo; Borja Del Pozo-Cruz; José C Adsuar; José Manuel Cordero-Ferrera; José María Abellán-Perpiñán; Fernando Ignacio Sánchez-Martínez
Journal:  Patient       Date:  2018-12       Impact factor: 3.883

4.  Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: the OPAL RCT.

Authors:  Suzanne Hagen; Carol Bugge; Sarah G Dean; Andrew Elders; Jean Hay-Smith; Mary Kilonzo; Doreen McClurg; Mohamed Abdel-Fattah; Wael Agur; Federico Andreis; Joanne Booth; Maria Dimitrova; Nicola Gillespie; Cathryn Glazener; Aileen Grant; Karen L Guerrero; Lorna Henderson; Marija Kovandzic; Alison McDonald; John Norrie; Nicole Sergenson; Susan Stratton; Anne Taylor; Louise R Williams
Journal:  Health Technol Assess       Date:  2020-12       Impact factor: 4.014

5.  Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China.

Authors:  Jie Jiang; Yanming Hong; Tiantian Zhang; Zhihao Yang; Tengfei Lin; Zhuoru Liang; Peiyao Lu; Lishun Liu; Binyan Wang; Yongmei Xu; Nan Luo
Journal:  Qual Life Res       Date:  2021-04-05       Impact factor: 4.147

6.  Close-Person Spill-Overs in End-of-Life Care: Using Hierarchical Mapping to Identify Whose Outcomes to Include in Economic Evaluations.

Authors:  Alastair Canaway; Hareth Al-Janabi; Philip Kinghorn; Cara Bailey; Joanna Coast
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

Review 7.  Screening for postnatal depression in primary care: cost effectiveness analysis.

Authors:  Mike Paulden; Stephen Palmer; Catherine Hewitt; Simon Gilbody
Journal:  BMJ       Date:  2009-12-22

8.  The association between legal Japanese visual impairment grades and vision-related quality of life.

Authors:  Motoko Kawashima; Yoshimune Hiratsuka; Tadashi Nakano; Hiroshi Tamura; Koichi Ono; Akira Murakami; Sachiko Inoue; Kazuo Tsubota; Masakazu Yamada
Journal:  Jpn J Ophthalmol       Date:  2016-03-14       Impact factor: 2.447

9.  Methods for identifying the cost-effective case definition cut-off for sequential monitoring tests: an extension of Phelps and Mushlin.

Authors:  Roberta Longo; Paul Baxter; Peter Hall; Jenny Hewison; Mehran Afshar; Geoff Hall; Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2014-04       Impact factor: 4.981

10.  An economic evaluation of a self-management programme of activity, coping and education for patients with chronic obstructive pulmonary disease.

Authors:  Melina Dritsaki; Vicki Johnson-Warrington; Katy Mitchell; Sally Singh; Karen Rees
Journal:  Chron Respir Dis       Date:  2015-12-23       Impact factor: 2.444
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.